文献速递脑血管病

皮质表面铁沉积的进展及其临床意义

Cortical Superficial Siderosis Evolution.
PubMed 文献 · Stroke · 2019-01-01

本研究纳入118例 probable 脑淀粉样血管病(CAA)患者,基线无脑出血,随访MRI评估皮质表面铁沉积(cSS)进展。中位扫描间隔2.2年,28%患者出现cSS进展;cSS进展独立预测症状性脑出血风险(HR 3.76)。

要点

  • cSS进展见于28%的CAA患者,基线cSS存在和播散性cSS是独立预测因素。
  • cSS进展独立增加症状性脑出血风险(HR 3.76,95%CI 1.37-10.35)。
  • cSS进展或可作为CAA疾病进展和出血风险的生物标志物。

核心结论

  • cSS进展可能是有用的生物标志物,用于评估CAA疾病进展和脑出血风险。

研究设计与样本

  • 单中心队列研究,纳入118例符合改良Boston标准的probable CAA患者,基线无脑出血,均有基线和随访MRI。

主要发现

  • 中位扫描间隔2.2年(IQR 1.2-4.4年),33例(28%)患者出现cSS进展。
  • 基线cSS存在(OR 4.04;95%CI 1.53-10.70;P=0.005)和播散性cSS(OR 9.12;95%CI 2.85-29.18;P<0.0001)及新发脑叶微出血(OR 4.24;95%CI 1.29-13.9;P=0.017)独立预测cSS进展。
  • 在扫描间期无脑出血的患者(n=105)中,cSS进展独立预测症状性脑出血风险(HR 3.76;95%CI 1.37-10.35;P=0.010)。

临床怎么用

  • 对CAA患者随访MRI评估cSS进展,可能有助于识别脑出血高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- We investigated cortical superficial siderosis (cSS) progression and its clinical relevance for incident lobar intracerebral hemorrhage (ICH) risk, in probable cerebral amyloid angiopathy presenting with neurological symptoms and without ICH at baseline. Methods- Consecutive patients meeting modified Boston criteria for probable cerebral amyloid angiopathy from a single-center cohort who underwent magnetic resonance imaging (MRI) at baseline and during follow-up were analyzed. cSS progression was assessed by comparison of the baseline and follow-up images. Patients were followed prospectively for incident symptomatic ICH. cSS progression and first-ever ICH risk were investigated in Cox proportional hazard models adjusting for confounders. Results- The cohort included 118 probable cerebral amyloid angiopathy patients: 72 (61%) presented with transient focal neurological episodes and 46 (39%) with cognitive complaints prompting the baseline MRI investigation. Fifty-two patients (44.1%) had cSS at baseline. During a median scan interval of 2.2 years (interquartile range, 1.2-4.4 years) between the baseline (ie, first) MRI and the latest MRI, cSS progression was detected in 33 (28%) patients. In multivariable logistic regression, baseline cSS presence (odds ratio, 4.04; 95% CI, 1.53-10.70; P=0.005), especially disseminated cSS (odds ratio, 9.12; 95% CI, 2.85-29.18; P<0.0001) and appearance of new lobar microbleeds (odds ratio, 4.24; 95% CI, 1.29-13.9; P=0.017) were independent predictors of cSS progression. For patients without an ICH during the interscan interval (n=105) and subsequent follow-up (median postfinal MRI time, 1.34; interquartile range, 0.3-3 years), cSS progression independently predicted increased symptomatic ICH risk (hazard ratio, 3.76; 95% CI, 1.37-10.35; P=0.010). Conclusions- Our results suggest that cSS evolution may be a useful biomarker for assessing disease progression and ICH risk in cerebral amyloid angiopathy patients and a candidate biomarker for clinical studies and trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019. PMID: 30869563. doi:10.1161/STROKEAHA.118.023368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。